"Turning to 2018, at the mid-point of the Q1 revenue guidance, we see 4% growth over Q1 of 2017. Our view of the 2018 SemiTest market outlook has also strengthened slightly since our October estimate. On the capital allocation front, the combination of a strong business outlook and U.S. tax reform support our plan to raise our quarterly dividend by 29% to $0.09 cents per share and initiate a $1.5 billion share repurchase program with expected repurchases of $750 million in 2018."
Teradyne’s Board of Directors approved the share repurchase program authorizing the Company to repurchase up to $1.5 billion of its common stock through open market purchases or private transactions. The $1.5 billion authorization replaces the Company’s existing $500 million repurchase authorization announced in December 2016.
Teradyne’s Board of Directors declared a quarterly cash dividend of $0.09 per share, payable on March 23, 2018 to shareholders of record as of the close of business on February 23, 2018.
Guidance for the first quarter of 2018 is revenue of $460 million to $490 million, with GAAP net income of $0.32 to $0.39 per diluted share and non-GAAP net income of $0.38 to $0.45 per diluted share. Non-GAAP guidance excludes acquired intangible asset amortization, non-cash convertible debt interest, restructuring and other charges and includes the related tax impact on non-GAAP adjustments.
______________________
1 Amount represents the estimated impact of the Tax Cuts and Jobs Act, which may change as additional guidance and information become available.
Webcast
A conference call to discuss the fourth quarter results, along with management's business outlook, will follow at 10 a.m. ET, Thursday, January 25. Interested investors should access the webcast at
www.teradyne.com and click on "Investors" at least five minutes before the call begins. Presentation materials will be available starting at 10 a.m. ET. A replay will be available on the Teradyne website at
www.teradyne.com/investors.
Non-GAAP Results
In addition to disclosing results that are determined in accordance with GAAP, Teradyne also discloses non-GAAP results of operations that exclude certain income items and charges. These results are provided as a complement to results provided in accordance with GAAP. Non-GAAP income from operations and non-GAAP net income exclude acquired intangible assets amortization, non-cash convertible debt interest, pension actuarial gains and losses, discrete income tax adjustments, goodwill impairment, acquired intangible assets impairment, and restructuring and other. GAAP requires that these items be included in determining income from operations and net income. Non-GAAP income from operations, non-GAAP net income, non-GAAP income from operations and non-GAAP net income as a percentage of revenue, and non-GAAP net income per share are non-GAAP performance measures presented to provide meaningful supplemental information regarding Teradyne’s baseline performance before gains, losses or other charges that may not be indicative of Teradyne’s current core business or future outlook. These non-GAAP performance measures are used to make operational decisions, to determine employee compensation, to forecast future operational results, and for comparison with Teradyne’s business plan, historical operating results and the operating results of Teradyne’s competitors. Non-GAAP gross margin excludes pension actuarial gains and losses. GAAP requires that these items be included in determining gross margin. Non-GAAP gross margin dollar amount and percentage are non-GAAP performance measures that management believes provide useful supplemental information for management and the investor. Management uses non-GAAP gross margin as a performance measure for Teradyne’s current core business and future outlook and for comparison with Teradyne’s business plan, historical gross margin results and the gross margin results of Teradyne’s competitors. Management believes each of these non-GAAP performance measures provides useful supplemental information for investors, allowing greater transparency to the information used by management in its operational decision making and in the review of Teradyne’s financial and operational performance, as well as facilitating meaningful comparisons of Teradyne’s results in the current period compared with those in prior and future periods. A reconciliation of each available GAAP to non-GAAP financial measure discussed in this press release is contained in the attached exhibits and on the Teradyne website at www.teradyne.com by clicking on “Investors” and then selecting the “GAAP to Non-GAAP Reconciliation” link. The non-GAAP performance measures discussed in this press release may not be comparable to similarly titled measures used by other companies. The presentation of non-GAAP measures is not meant to be considered in isolation, as a substitute for, or superior to, financial measures or information provided in accordance with GAAP.
About Teradyne
Teradyne (NYSE:TER) is a leading supplier of automation equipment for test and industrial applications. Teradyne Automatic Test Equipment (ATE) is used to test semiconductors, wireless products, data storage and complex electronic systems, which serve consumer, communications, industrial and government customers. Our Industrial Automation products include collaborative robots used by global manufacturing and light industrial customers to improve quality and increase manufacturing efficiency. In 2017, Teradyne had revenue of $2.14 billion and currently employs approximately 4,500 people worldwide. For more information, visit
www.teradyne.com. Teradyne(R) is a registered trademark of Teradyne, Inc. in the U.S. and other countries.
Safe Harbor Statement
This release contains forward-looking statements regarding Teradyne’s future business prospects, results of operations, market conditions, earnings per share, the payment of a quarterly dividend, the repurchase of Teradyne common stock pursuant to a share repurchase program, use of proceeds and potential dilution from the senior convertible notes offering, potential borrowings under a senior secured credit facility, and the impact of the U.S. tax reform law. Such statements are based on the current assumptions and expectations of Teradyne’s management and are neither promises nor guarantees of future performance, events, earnings per share, use of cash, payment of dividends, repurchases of common stock, payment of the senior convertible notes, availability of, or borrowing under, the credit facility, or the impact of the U.S. tax reform law. There can be no assurance that management’s estimates of Teradyne’s future results or other forward-looking statements will be achieved. Additionally, the current dividend and share repurchase programs may be modified, suspended or discontinued at any time. Important factors that could cause actual results, earnings per share, use of cash, dividend payments, repurchases of common stock, payment of the senior convertible notes or borrowings under the credit facility to differ materially from those presently expected include: conditions affecting the markets in which Teradyne operates; decreased or delayed product demand from one or more significant customers; development, delivery and acceptance of new products; the ability to grow Universal Robots’ business; increased research and development spending; deterioration of Teradyne’s financial condition; the consummation and success of any mergers or acquisitions; unexpected cash needs; insufficient cash flow to make required payments and pay the principal amount on the senior convertible notes; the business judgment of the board of directors that a declaration of a dividend, the repurchase of common stock or borrowing under the credit facility is not in the company’s best interests; additional U.S. tax regulations or IRS guidance; and other events, factors and risks disclosed in filings with the SEC, including, but not limited to, the “Risk Factors” section of Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016 and the Quarterly Report on Form 10-Q for the period ended October 1, 2017. The forward-looking statements provided by Teradyne in this press release represent management’s views as of the date of this release. Teradyne anticipates that subsequent events and developments may cause management’s views to change. However, while Teradyne may elect to update these forward-looking statements at some point in the future, Teradyne specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Teradyne’s views as of any date subsequent to the date of this release.
TERADYNE, INC. REPORT FOR FOURTH FISCAL QUARTER OF 2017 | ||||||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||||||||
(In thousands, except per share amounts) | ||||||||||||||||||||||
Quarter Ended | Twelve Months Ended | |||||||||||||||||||||
December 31, 2017 | October 1, 2017 | December 31, 2016 | December 31, 2017 | December 31, 2016 | ||||||||||||||||||
Net revenues
| $ | 479,415 | $ | 503,378 | $ | 379,989 | $ | 2,136,606 | $ | 1,753,250 | ||||||||||||
Cost of revenues (exclusive of acquired intangible assets amortization
shown separately below) (1) (2) | 206,480 | 208,592 | 160,983 | 912,734 | 793,683 | |||||||||||||||||
Gross profit | 272,935 | 294,786 | 219,006 | 1,223,872 | 959,567 | |||||||||||||||||
Operating expenses: | ||||||||||||||||||||||
Selling and administrative (1) | 88,006 | 86,244 | 76,289 | 348,287 | 315,682 | |||||||||||||||||
Engineering and development (1) | 70,564 | 77,190 | 70,052 | 305,665 | 291,025 | |||||||||||||||||
Acquired intangible assets amortization | 7,384 | 7,028 | 7,923 | 30,530 | 52,648 | |||||||||||||||||
Restructuring and other (3) | 8,970 | (4,407 | ) | 5,570 | 9,362 | 21,942 | ||||||||||||||||
Goodwill impairment (4) | - | - | - | - | 254,946 | |||||||||||||||||
Acquired intangible assets impairment (4) | - | - | - | - | 83,339 | |||||||||||||||||
Operating expenses | 174,924 | 166,055 | 159,834 | 693,844 | 1,019,582 | |||||||||||||||||
Income (loss) from operations | 98,011 | 128,731 | 59,172 | 530,028 | (60,015 | ) | ||||||||||||||||
Interest and other (5) | 73 | (1,294 | ) | (288 | ) | (5,616 | ) | 4,955 | ||||||||||||||
Income (loss) before income taxes | 98,084 | 127,437 | 58,884 | 524,412 | (55,060 | ) | ||||||||||||||||
Income tax provision (benefit) (6) | 204,007 | 24,017 | (7,461 | ) | 266,720 | (11,639 | ) | |||||||||||||||
Net (loss) income | $ | (105,923 | ) | $ | 103,420 | $ | 66,345 | $ | 257,692 | $ | (43,421 | ) | ||||||||||
Net (loss) income per common share: | ||||||||||||||||||||||
Basic | $ | (0.54 | ) | $ | 0.52 | $ | 0.33 | $ | 1.30 | $ | (0.21 | ) | ||||||||||
Diluted | $ | (0.54 | ) | $ | 0.52 | $ | 0.33 | $ | 1.28 | $ | (0.21 | ) | ||||||||||
Weighted average common shares - basic | 196,010 | 197,485 | 200,810 | 198,069 | 202,578 | |||||||||||||||||
Weighted average common shares - diluted (7) | 196,010 | 200,775 | 202,947 | 201,641 | 202,578 | |||||||||||||||||
Cash dividend declared per common share | $ | 0.07 | $ | 0.07 | $ | 0.06 | $ | 0.28 | $ | 0.24 | ||||||||||||
Net orders | $ | 559,869 | $ | 410,229 | $ | 628,284 | $ | 2,026,436 | $ | 1,867,146 | ||||||||||||
(1 | ) | Pension actuarial (gains) losses included in our operating results were as follows: | ||||||||||||||||||||
Quarter Ended | Twelve Months Ended | |||||||||||||||||||||
December 31, 2017 | October 1, 2017 | December 31, 2016 | December 31, 2017 | December 31, 2016 | ||||||||||||||||||
Cost of revenues | $ | (2,088 | ) | $ | - | $ | (774 | ) | $ | (2,752 | ) | $ | (1,025 | ) | ||||||||
Engineering and development | (1,710 | ) | - | (725 | ) | (2,456 | ) | (1,234 | ) | |||||||||||||
Selling and administrative | 12 | - | (502 | ) | (1,082 | ) | (944 | ) | ||||||||||||||
$ | (3,786 | ) | $ | - | $ | (2,001 | ) | $ | (6,290 | ) | $ | (3,203 | ) | |||||||||
(2 | ) | Cost of revenues includes: | Quarter Ended | Twelve Months Ended | ||||||||||||||||||
December 31, 2017 | October 1, 2017 | December 31, 2016 | December 31, 2017 | December 31, 2016 | ||||||||||||||||||
Provision for excess and obsolete inventory | $ | 1,690 | $ | 1,859 | $ | 2,345 | $ | 8,844 | $ | 17,493 | ||||||||||||
Sale of previously written down inventory | (1,048 | ) | (3,121 | ) | (1,924 | ) | (7,451 | ) | (10,037 | ) | ||||||||||||
$ | 642 | $ | (1,262 | ) | $ | 421 | $ | 1,393 | $ | 7,456 | ||||||||||||
(3 | ) | Restructuring and other consists of: | Quarter Ended | Twelve Months Ended | ||||||||||||||||||
December 31, 2017 | October 1, 2017 | December 31, 2016 | December 31, 2017 | December 31, 2016 | ||||||||||||||||||
Contingent consideration fair value adjustment | $ | 5,973 | $ | (286 | ) | $ | 5,445 | $ | 7,820 | $ | 15,896 | |||||||||||
Employee severance | 1,801 | 581 | 125 | 3,754 | 6,046 | |||||||||||||||||
Impairment of fixed assets | 1,124 | - | - | 1,124 | - | |||||||||||||||||
Facility related | 72 | (393 | ) | - | 973 | - | ||||||||||||||||
Property insurance recovery | - | (5,064 | ) | - | (5,064 | ) | (5,363 | ) | ||||||||||||||
Expenses and impairment of fixed assets related to Japan earthquake | - | 755 | - | 755 | 5,363 | |||||||||||||||||
$ | 8,970 | $ | (4,407 | ) | $ | 5,570 | $ | 9,362 | $ | 21,942 | ||||||||||||
(4 | ) | Goodwill and acquired intangible assets impairment related to Teradyne's Wireless Test business segment. | ||||||||||||||||||||
(5 | ) | Interest and other includes: | Quarter Ended | Twelve Months Ended | ||||||||||||||||||
December 31, 2017 | October 1, 2017 | December 31, 2016 | December 31, 2017 | December 31, 2016 | ||||||||||||||||||
Non-cash convertible debt interest expense | $ | 3,166 | $ | 3,127 | $ | 642 | $ | 12,431 | $ | 642 | ||||||||||||
(6 | ) | For the quarter and twelve months ended December 31, 2017, income tax provision includes an expense of $184 million related to the estimated impact of U.S. tax policy changes. | ||||||||||||||||||||
(7 | ) | Under GAAP, when calculating diluted earnings per share, convertible debt must be assumed to have converted if the effect on EPS would be dilutive. Diluted shares assume the conversion of the convertible debt as the effect would be dilutive. Accordingly, for the quarter ended October 1, 2017 and the twelve months ended December 31, 2017, 1.1 million and 1.3 million shares, respectively, have been included in diluted shares. | ||||||||||||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) | ||||||||||||||||||||||
December 31, 2017 | December 31, 2016 | |||||||||||||||||||||
Assets | ||||||||||||||||||||||
Cash and cash equivalents | $ | 429,843 | $ | 307,884 | ||||||||||||||||||
Marketable securities | 1,347,979 | 871,024 | ||||||||||||||||||||
Accounts receivable, net | 272,783 | 192,444 | ||||||||||||||||||||
Inventories, net | 107,525 | 135,958 | ||||||||||||||||||||
Prepayments and other current assets | 112,151 | 116,493 | ||||||||||||||||||||
Total current assets | 2,270,281 | 1,623,803 | ||||||||||||||||||||
Property, plant and equipment, net | 268,447 | 253,821 | ||||||||||||||||||||
Marketable securities | 125,926 | 433,843 | ||||||||||||||||||||
Deferred tax assets | 84,026 | 107,405 | ||||||||||||||||||||
Retirement plans assets | 17,491 | 7,712 | ||||||||||||||||||||
Other assets | 12,275 | 12,165 | ||||||||||||||||||||
Acquired intangible assets, net | 79,088 | 100,401 | ||||||||||||||||||||
Goodwill | 252,011 | 223,343 | ||||||||||||||||||||
Total assets | $ | 3,109,545 | $ | 2,762,493 | ||||||||||||||||||
Liabilities | ||||||||||||||||||||||
Accounts payable | $ | 86,393 | $ | 95,362 | ||||||||||||||||||
Accrued employees' compensation and withholdings | 141,694 | 109,944 | ||||||||||||||||||||
Deferred revenue and customer advances | 83,614 | 84,478 | ||||||||||||||||||||
Other accrued liabilities | 59,083 | 51,382 | ||||||||||||||||||||
Contingent consideration | 24,497 | 1,050 | ||||||||||||||||||||
Income taxes payable | 59,055 | 30,480 | ||||||||||||||||||||
Total current liabilities | 454,336 | 372,696 | ||||||||||||||||||||
Retirement plans liabilities | 119,776 | 106,938 | ||||||||||||||||||||
Long-term deferred revenue and customer advances | 30,127 | 23,463 | ||||||||||||||||||||
Long-term contingent consideration | 20,605 | 37,282 | ||||||||||||||||||||
Deferred tax liabilities | 6,720 | 12,144 | ||||||||||||||||||||
Long-term other accrued liabilities | 10,273 | 28,642 | ||||||||||||||||||||
Long-term income taxes payable | 148,075 | - | ||||||||||||||||||||
Long-term debt | 365,987 | 352,669 | ||||||||||||||||||||
Total liabilities | 1,155,899 | 933,834 | ||||||||||||||||||||
Shareholders' equity | 1,953,646 | 1,828,659 | ||||||||||||||||||||
Total liabilities and shareholders' equity | $ | 3,109,545 | $ | 2,762,493 | ||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) | ||||||||||||||||||||||
Quarter Ended | Twelve Months Ended | |||||||||||||||||||||
December 31, 2017 | December 31, 2016 | December 31, 2017 | December 31, 2016 | |||||||||||||||||||
Cash flows from operating activities: | ||||||||||||||||||||||
Net (loss) income | $ | (105,923 | ) | $ | 66,345 | $ | 257,692 | $ | (43,421 | ) | ||||||||||||
Adjustments to reconcile net (loss) income to net cash provided by operating activities: | ||||||||||||||||||||||
Depreciation | 16,879 | 16,345 | 66,122 | 64,782 | ||||||||||||||||||
Amortization | 9,640 | 8,952 | 41,953 | 55,227 | ||||||||||||||||||
Stock-based compensation | 8,477 | 7,738 | 34,097 | 30,750 | ||||||||||||||||||
Contingent consideration fair value adjustment | 5,973 | 5,445 | 7,820 | 15,896 | ||||||||||||||||||
Provision for excess and obsolete inventory | 1,690 | 2,345 | 8,844 | 17,493 | ||||||||||||||||||
Retirement plans actuarial gains | (3,786 | ) | (2,001 | ) | (6,290 | ) | (3,203 | ) | ||||||||||||||
Deferred taxes | 37,784 | (20,368 | ) | 37,105 | (62,936 | ) | ||||||||||||||||
Property insurance recovery | - | - | (4,309 | ) | - | |||||||||||||||||
Tax benefit related to employee stock compensation awards | - | (2,799 | ) | - | (6,198 | ) | ||||||||||||||||
Goodwill impairment | - | - | - | 254,946 | ||||||||||||||||||
Acquired intangible assets impairment | - | - | - | 83,339 | ||||||||||||||||||
Other | (165 | ) | (597 | ) | 266 | (448 | ) | |||||||||||||||
Changes in operating assets and liabilities: | ||||||||||||||||||||||
Accounts receivable | (4,961 | ) | (27,955 | ) | (80,584 | ) | 18,325 | |||||||||||||||
Inventories | 21,190 | (14,338 | ) | 44,960 | 34,263 | |||||||||||||||||
Prepayments and other assets | (5,108 | ) | (5,924 | ) | 2,254 | (19,194 | ) | |||||||||||||||
Accounts payable and accrued expenses | 42,350 | 46,404 | 47,648 | 6,820 | ||||||||||||||||||
Deferred revenue and customer advances | (29,551 | ) | (57,014 | ) | 4,984 | (3,634 | ) | |||||||||||||||
Retirement plans contributions | (1,044 | ) | (173 | ) | (5,902 | ) | (6,044 | ) | ||||||||||||||
Income taxes | 154,027 | 14,207 | 169,835 | 18,434 | ||||||||||||||||||
Net cash provided by operating activities | 147,472 | 36,612 | 626,495 | 455,197 | ||||||||||||||||||
Cash flows from investing activities: | ||||||||||||||||||||||
Purchases of property, plant and equipment | (32,128 | ) | (19,020 | ) | (105,375 | ) | (85,272 | ) | ||||||||||||||
Purchases of available-for-sale marketable securities | (355,394 | ) | (780,430 | ) | (1,391,917 | ) | (1,656,267 | ) | ||||||||||||||
Proceeds from sales of available-for-sale marketable securities | 84,577 | 386,050 | 527,746 | 852,794 | ||||||||||||||||||
Proceeds from maturities of available-for-sale marketable securities | 228,426 | 41,070 | 701,681 | 243,232 | ||||||||||||||||||
Proceeds from property insurance | - | - | 5,064 | 5,051 | ||||||||||||||||||
Net cash used for investing activities | (74,519 | ) | (372,330 | ) | (262,801 | ) | (640,462 | ) | ||||||||||||||
Cash flows from financing activities: | ||||||||||||||||||||||
Issuance of common stock under stock purchase and stock option plans | 31 | 388 | 24,493 | 20,473 | ||||||||||||||||||
Repurchase of common stock | (48,482 | ) | (61,239 | ) | (200,304 | ) | (146,331 | ) | ||||||||||||||
Dividend payments | (13,717 | ) | (12,071 | ) | (55,447 | ) | (48,619 | ) | ||||||||||||||
Payments related to net settlement of employee stock compensation awards | (297 | ) | (169 | ) | (12,881 | ) | (9,398 | ) | ||||||||||||||
Proceeds from long-term debt, net | - | 417,818 | - | 417,818 | ||||||||||||||||||
Tax benefit related to employee stock compensation awards | - | 2,799 | - | 6,198 | ||||||||||||||||||
Payments of contingent consideration | - | - | (1,050 | ) | (11,697 | ) | ||||||||||||||||
Net cash (used for) provided by financing activities | (62,465 | ) | 347,526 | (245,189 | ) | 228,444 | ||||||||||||||||
Effects of exchange rate changes on cash and cash equivalents | 678 | (1,861 | ) | 3,454 | - | |||||||||||||||||
Increase in cash and cash equivalents | 11,166 | 9,947 | 121,959 | 43,179 | ||||||||||||||||||
Cash and cash equivalents at beginning of period | 418,677 | 297,937 | 307,884 | 264,705 | ||||||||||||||||||
Cash and cash equivalents at end of period | $ | 429,843 | $ | 307,884 | $ | 429,843 | $ | 307,884 | ||||||||||||||